Loading...
XTAI
1731
Market cap85mUSD
Jul 09, Last price  
20.65TWD
1D
0.00%
1Q
-5.28%
Jan 2017
50.73%
IPO
117.85%
Name

Maywufa Co Ltd

Chart & Performance

D1W1MN
XTAI:1731 chart
P/E
15.16
P/S
1.73
EPS
1.36
Div Yield, %
5.81%
Shrs. gr., 5y
-0.05%
Rev. gr., 5y
8.26%
Revenues
1.58b
+6.61%
2,858,709,0003,009,097,0002,247,147,0002,146,907,0001,512,329,0001,232,868,0001,369,188,0001,443,068,0001,575,078,0001,123,398,0001,100,863,0001,065,325,0001,289,211,0001,245,105,0001,300,721,0001,485,873,0001,584,065,000
Net income
181m
+4.49%
57,629,00058,107,00042,090,00059,721,00063,573,00080,524,00079,086,00090,733,00085,937,00075,765,000100,605,000171,002,000164,321,000161,830,000169,098,000173,232,000181,002,000
CFO
228m
+5.64%
-12,393,00091,476,00051,699,000269,007,000122,416,000203,800,000155,604,00067,022,000225,630,000228,458,000217,457,000240,462,000262,975,000147,884,000244,319,000215,695,000227,855,000
Dividend
Jun 30, 20251.2 TWD/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Maywufa Company Ltd. manufactures and sells hair and skin care products under the Maywufa brand in Taiwan. The company engages in the manufacturing, processing, and distribution of hairdressing products, soap, and cosmetics; distribution, wholesale, and retail trading of various beauty products, health products, and sports equipment; retail and wholesale business of health food, such as vitamin pills and oral liquid nutrients; trading, wholesale, and retail of medical drugs and medical equipment; wholesale and retail sales of food, baby products, and general food products; and wholesale trading and agency business. It also provides consulting and analysis; warehousing services; and mother and baby skin care products under the Mustela brand. In addition, the company provides pharmaceuticals and medical devices, such as PG2 Lyophilized injection for treatment of cancer-related fatigue; AmCad-UT Detection device, an ultrasound CAD for thyroid cancer detection; Bio-Three tablets for the treatment of mild diarrhea, abdominal pain, and constipation; and Cerebrolysin, a supplementary nutrient boost for patients who cannot ingest adequate food and patients who have difficulties in the digestion, absorption, synthesis, and utilization of proteins, as well as for patients suffering from severe trauma, burns, fractures, insufficient protein intake, or malnutrition. Maywufa Company Ltd. was incorporated in 1976 and is headquartered in Taipei, Taiwan.
IPO date
Sep 17, 2001
Employees
Domiciled in
TW
Incorporated in
TW

Valuation

Title
TWD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT